Idiopathic Thrombocytopenic Purpera
Presentation
Growth of primary PCI for the treatment of heart attack patients in England 2008-2011: the role of NHS Improvement and the cardiac networks
The Evolving Science and Controversial Landscape of Antiplatelet Therapy in the Catheterization Laboratory Mechanisms Mortality Therapeutics PROGRAM CO-CHAIRMAN.
Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention.
FAUT-IL ENCORE RECHERCHER UNE STENOSE ARTERIELLE RENALE ? Docteur Guillaume BOBRIE Service dHTA - HEGP - Paris.
Irrational Exuberance: Component Therapy Before Bedside Procedures Jeannie Callum, BA, MD, FRCPC, CTBS Sunnybrook Health Sciences Centre Associate Professor,
Stroke prevention in atrial fibrillation: current limitations and novel antithrombotic agents Module 5.
EMORRAGIA COAGULAZIONE TROMBOSI LEMERGENZA E OLTRE Mantova 17 Aprile 2010 Ricoagulare il paziente scoagulato farmacologicamente Franco Manzato.
PROGRAM DIRECTOR: Dr. Steven Laster
Polycythemia
Actualizaciones en SDRA Pediátrico
